Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Neuroimmune Pharmacol ; 18(4): 690-703, 2023 12.
Article de Anglais | MEDLINE | ID: mdl-38041701

RÉSUMÉ

The etiology of neuropathic pain is mostly caused by mechanical deformation and neuroinflammation, of which neuroinflammation is the main cause of chronic neuropathic pain. Activation of the TLR4/NF-κB signaling pathway mediates elevated levels of inflammatory cytokines, and we clearly demonstrated by in vivo and in vitro Western blot experiments that ß-sitosterol significantly inhibited the elevated Toll-like receptor 4 (TLR4) expression levels and nuclear factor-kappa B (NF-κB) activation associated with inflammatory responses. In cellular experiments, we clearly saw that both ß-sitosterol and TLR4/NF-κB signaling pathway inhibitors could inhibit M1 proinflammatory phenotype expression and promote M2 anti-inflammatory phenotype expression in GMI-R1 microglia by flow cytometry and immunofluorescence assays. Therefore, we suggest that ß-sitosterol can affect microglial polarization by inhibiting the TLR4/NF-κB signaling pathway thereby reducing neuroinflammation and thus alleviating neuropathic pain.


Sujet(s)
Facteur de transcription NF-kappa B , Névralgie , Humains , Facteur de transcription NF-kappa B/métabolisme , Microglie/métabolisme , Maladies neuro-inflammatoires , Récepteur de type Toll-4/métabolisme , Transduction du signal/physiologie , Névralgie/traitement médicamenteux , Névralgie/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE